M Hansson Selected Research

M Hansson Research Topics

Disease

5	Neoplasms (Cancer) 01/2018 - 01/2000
3	Inflammation (Inflammations) 03/2014 - 12/2003
2	Multiple Myeloma 11/2017 - 08/2014
2	Arthritis (Polyarthritis) 03/2014 - 04/2009
2	Knee Injuries (Knee Injury) 08/2011 - 04/2009
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2018
1	Shock 11/2015
1	Neutropenia 08/2014
1	Rheumatoid Arthritis 03/2014
1	Sarcoma (Soft Tissue Sarcoma) 06/2012
1	Margins of Excision 06/2012
1	Wounds and Injuries (Trauma) 08/2011
1	Major Depressive Disorder (Major Depressive Disorders) 01/2011
1	Joint Diseases (Joint Disease) 04/2009
1	Liver Diseases (Liver Disease) 08/2007
1	Cerebrotendinous Xanthomatosis 05/2007
1	Thyroid Diseases (Thyroid Disease) 07/2006
1	Autoimmune Diseases (Autoimmune Disease) 05/2004
1	Fibrosis (Cirrhosis) 05/2004
1	Disseminated Intravascular Coagulation 12/2003
1	Sepsis (Septicemia) 12/2003
1	Endotoxemia 12/2003
1	Communicable Diseases (Infectious Diseases) 10/2000
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2000
1	Hematologic Neoplasms (Hematological Malignancy) 08/2000
1	Type 2 Diabetes Mellitus (MODY) 04/2000
1	Hyperglycemia 04/2000
1	Melanoma (Melanoma, Malignant) 01/2000
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2000

Drug/Important Bio-Agent (IBA)

4	Histamine (Histamine Dihydrochloride)FDA Link 11/2000 - 01/2000
3	Interleukin-2 (IL2)IBA 11/2000 - 01/2000
2	AntibodiesIBA 01/2018 - 10/2000
2	pomalidomideIBA 11/2017 - 08/2014
2	AutoantibodiesIBA 03/2014 - 05/2004
2	Biomarkers (Surrogate Marker)IBA 08/2011 - 04/2009
2	Aggrecans (Aggrecan)IBA 08/2011 - 04/2009
2	EnzymesIBA 05/2007 - 04/2000
2	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2000 - 01/2000
1	Monoclonal AntibodiesIBA 01/2018
1	Rituximab (Mabthera)FDA Link 01/2018
1	HLA-DR Antigens (HLA-DR)IBA 01/2018
1	Alkylating AgentsIBA 11/2017
1	Bortezomib (Velcade)FDA Link 11/2017
1	carfilzomibIBA 11/2017
1	Lenalidomide (CC 5013)FDA Link 11/2017
1	Anti-Citrullinated Protein AntibodiesIBA 03/2014
1	Rheumatoid FactorIBA 03/2014
1	cyclic citrullinated peptideIBA 03/2014
1	Immunoglobulin M (IgM)IBA 03/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2012
1	Melphalan (Alkeran)FDA LinkGeneric 06/2012
1	Chondroitin Sulfates (Chondroitin Sulfate)IBA 08/2011
1	aggrecanaseIBA 08/2011
1	Immunoglobulin D (IgD)IBA 08/2011
1	cesium chloride (CsCl)IBA 04/2009
1	Bile Acids and Salts (Bile Acids)IBA 08/2007
1	Cholestanetriol 26-Monooxygenase (Cholestanetriol 26 Monooxygenase)IBA 05/2007
1	IodineIBA 07/2006
1	Protein CIBA 05/2005
1	ThrombomodulinIBA 05/2005
1	Mercuric Chloride (Sublimate)IBA 05/2004
1	MercuryIBA 05/2004
1	Immunoglobulins (Immunoglobulin)IBA 05/2004
1	Immunoglobulin G (IgG)IBA 05/2004
1	Immunoglobulin E (IgE)IBA 05/2004
1	Niacinamide (Nicotinamide)FDA LinkGeneric 12/2003
1	Oxygen (Dioxygen)IBA 11/2000
1	Humanized Monoclonal AntibodiesIBA 10/2000
1	Subunit VaccinesIBA 10/2000
1	Recombinant ProteinsIBA 10/2000
1	Proteins (Proteins, Gene)FDA Link 10/2000
1	Immunoglobulin FragmentsIBA 10/2000
1	Glycogen Synthase (Synthase I)IBA 04/2000
1	GlycogenIBA 04/2000
1	Messenger RNA (mRNA)IBA 04/2000
1	Insulin (Novolin)FDA Link 04/2000
1	Histamine H2 ReceptorsIBA 01/2000

Therapy/Procedure

5	Therapeutics 11/2017 - 02/2000
3	Immunotherapy 11/2000 - 01/2000
1	Lasers (Laser) 11/2015
1	Surgical Amputation (Amputations) 06/2012
1	Deep Brain Stimulation 01/2011
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 08/2000